Cargando…
Incidence of Mutation and Deletion in Topoisomerase IIα mRNA of Etoposide and mAMSA–resistant Cell Lines
The efficacy of all chemotherapeutic agents is limited by the occurrence of drug resistance. To further understand resistance to topoisomerase II inhibitors, 50 sublines were isolated as single clones from parental cells by exposure to VP–16 (etoposide) or mAMSA (m–amsacrine). Subsequently, a popula...
Autores principales: | Matsumoto, Yoshihito, Takano, Hiroshi, Kunishio, Katsuzo, Nagao, Seigo, Fojo, Tito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926608/ https://www.ncbi.nlm.nih.gov/pubmed/11676865 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01069.x |
Ejemplares similares
-
Expression of Drug Resistance Genes in VP‐16 and mAMSA‐selected Human Carcinoma Cells
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal Truncation
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.
por: West, C., et al.
Publicado: (1981) -
mAMSA resistant human topoisomerase IIβ mutation G465D has reduced ATP hydrolysis activity
por: Gilroy, Kathryn L., et al.
Publicado: (2006) -
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
por: Withoff, S., et al.
Publicado: (1996)